GDOC Among Gold ETFs
End-of-day Nov 20, 2026 · 40 Gold ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | 0.0% | −4.9% | −1.4% | −2.0% | +5.4% | +4.5% | +28.0% | −3.3% | — | −3.3% |
| Peer average | −3.8% | −8.9% | −10.5% | −16.6% | −7.5% | −3.5% | +68.1% | +53.8% | +176.0% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$142 of every $1,000 in GDOC is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly | Healthcare | 14.20% | $1,420.07 | 2,066 | $2.8M |
| 2 | JNJJohnson & Johnson | Healthcare | 6.18% | $618.08 | 4,548 | $1.2M |
| 3 | UNHUnitedhealth Group Incorporated | Healthcare | 4.90% | $489.58 | 2,912 | $962K |
| 4 | EWEdwards Lifesciences | Healthcare | 4.89% | $488.51 | 9,244 | $960K |
| 5 | MRKMerck | Healthcare | 4.60% | $460.18 | 6,811 | $905K |
| 6 | VRTXVertex Pharmaceuticals Incorporated | Healthcare | 4.00% | $400.22 | 1,511 | $787K |
| 7 | AAgilent Technologies | Healthcare | 4.00% | $400.06 | 4,485 | $786K |
| 8 | DXCMDexcom | Healthcare | 3.99% | $399.05 | 9,782 | $784K |
| 9 | TMOThermo Fisher Scientific | Healthcare | 3.90% | $390.33 | 1,114 | $767K |
| 10 | AZN.LAstrazeneca ORD | Healthcare | 3.35% | $335.44 | 3,778 | $659K |
| 11 | GHGuardant Health | Healthcare | 3.27% | $326.70 | 4,411 | $642K |
| 12 | GILDGilead Sciences | Healthcare | 3.18% | $318.20 | 3,756 | $625K |
| 13 | LONN.SWLonza Group AG | Healthcare | 3.10% | $310.36 | 771 | $610K |
| 14 | ABBVAbbvie | Healthcare | 3.03% | $303.06 | 2,101 | $596K |
| 15 | CORCencora | Healthcare | 2.81% | $281.06 | 1,619 | $552K |
of the $254B in 46 Gold ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly & | 14.20% |
| 2 | JNJ | Johnson & Johnson | 6.18% |
| 3 | UNH | Unitedhealth Group Incorporated | 4.90% |
| 4 | EW | Edwards Lifesciences | 4.89% |
| 5 | MRK | Merck & | 4.60% |
| 6 | VRTX | Vertex Pharmaceuticals Incorporated | 4.00% |
| 7 | A | Agilent Technologies | 4.00% |
| 8 | DXCM | Dexcom | 3.99% |
| 9 | TMO | Thermo Fisher Scientific | 3.90% |
| 10 | AZN.L | Astrazeneca ORD | 3.35% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 23, 2025 | Dec 30, 2025 | $0.11 |
| Dec 23, 2024 | Dec 30, 2024 | $0.0058 |
| Dec 26, 2023 | Jan 2, 2024 | $0.18 |
| Sep 26, 2022 | Sep 30, 2022 | $0.0000 |